First Lutein Based Eyedrops Internationally Patented Skip to main content

01.10.2025

OMISAN Farmaceutici srl

First Lutein Based Eyedrops Internationally Patented

At Omisan we are absolutely thrilled to announce our innovative LuteVisial

#sterile #eyedrops ! The industry buzz confirms the market need for this unique, patented formulation.

LuteVisial is a Class IIb Medical Device that combines:

➡️ LUTEIN: A powerful #carotenoid #antioxidant that acts as a filter against blue light (400-500 nm) and UV rays, protecting the eye structures from phototoxic damage.

➡️ VITAMIN E: A strong liposomal antioxidant that helps counteract the oxidation of lipids and is used to keep Lutein stable in solution.

➡️ CARBOXYMETHYL CELLULOSE (CMC): a #polymer that provides a lubricating, hydrating and protective action by stabilizing the tear film and offering a "long-lasting" mucoadhesive effect.


LuteVisial is specifically indicated for:

✅ lubricating,

✅ hydrating

✅ protecting dry,

✅ dehydrated tired eyes,

✅ contribution to prevention and treatment of symptoms linked to #dryeyes caused by oxidative stress from exposure to light sources (like screens) or solar radiation. Providing a barrier effect against light damage and neutralizing free radicals.





Exhibitor Data Sheet
Return to top